AF
MBX

Allworth Financial’s MBX Biosciences MBX Stock Holding History

Allworth Financial’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65K Sell
48
-22
-31% -$768 ﹤0.01% 4395
2026
Q1 		$2.09K Buy
70
+18
+35% +$612 ﹤0.01% 4341
2025
Q4 		$1.64K Buy
52
+27
+108% +$655 ﹤0.01% 4206
2025
Q3 		$438 Hold
25
– – ﹤0.01% 4472
2025
Q2 		$286 Buy
+25
New +$255 ﹤0.01% 4259

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Allworth Financial's MBX Position: Q2 2026 in Review

Allworth Financial reduced its MBX Biosciences (MBX) stake by 31% in Q2 2026, selling an estimated $768 and leaving 48 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4395.

Allworth Financial first reported a position in MBX in Q2 2025 and has held it in 5 quarters since. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Allworth Financial held 48 shares of MBX Biosciences worth $2.65K as of Q2 2026.
  • Allworth Financial sold 22 MBX Biosciences shares in Q2 2026, an estimated $768.
  • MBX Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4395 holding.
  • Allworth Financial first reported a position in MBX Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.